Infectious complications of tumor necrosis factor-α antagonists

被引：24

作者：

Bakleh, M ^{[1
]}

Tleyjeh, I ^{[1
]}

Matteson, EL ^{[1
]}

Osmon, DR ^{[1
]}

Berbari, EF ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Div Infect Dis & Rheumatol, Dept Internal Med, Coll Med, Rochester, MN 55905 USA

来源：

INTERNATIONAL JOURNAL OF DERMATOLOGY | 2005年 / 44卷 / 06期

关键词：

D O I：

10.1111/j.1365-4632.2004.02571.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：443 / 448

页数：6

共 59 条

[11] Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: A possible healthcare-associated case? [J].

De Rosa, FG ;

Shaz, D ;

Campagna, AC ;

Dellaripa, PR ;

Khettry, U ;

Craven, DE .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2003, 24 (07) :477-482

[12] Tuberculous tonsillitis in a patient receiving etanercept treatment [J].

Derk, CT ;

DeHoratius, RJ .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (04) :372-372

[13] Infections and anti-TNF therapy: strategies for screening based on clinical experience [J].

Estrach, C ;

Abernethy, VE ;

Dawson, JK .

RHEUMATOLOGY, 2004, 43 (01) :115-116

[14] ELEVATED TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BIOLOGICAL-ACTIVITY IN PSORIATIC SKIN-LESIONS [J].

ETTEHADI, P ;

GREAVES, MW ;

WALLACH, D ;

ADERKA, D ;

CAMP, RDR .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 96 (01) :146-151

[15] TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE [J].

FLYNN, JL ;

GOLDSTEIN, MM ;

CHAN, J ;

TRIEBOLD, KJ ;

PFEFFER, K ;

LOWENSTEIN, CJ ;

SCHREIBER, R ;

MAK, TW ;

BLOOM, BR .

IMMUNITY, 1995, 2 (06) :561-572

[16] Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report [J].

Gómez-Reino, JJ ;

Carmona, L ;

Valverde, VR ;

Mola, EM ;

Montero, MD .

ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2122-2127

[17] Cerebral toxoplasmosis following etanercept treatment for idiophatic pneumonia syndrome after autologous peripheral blood progenitor cell transplantation (PBPCT) [J].

Gonzalez-Vicent, M ;

Diaz, MA ;

Sevilla, J ;

Madero, L .

ANNALS OF HEMATOLOGY, 2003, 82 (10) :649-653

[18] A randomized trial of etanercept as monotherapy for psoriasis [J].

Gottlieb, AB ;

Matheson, RT ;

Lowe, N ;

Krueger, GG ;

Kang, S ;

Goffe, BS ;

Gaspari, AA ;

Ling, M ;

Weinstein, GD ;

Nayak, A ;

Gordon, KB ;

Zitnik, R .

ARCHIVES OF DERMATOLOGY, 2003, 139 (12) :1627-1632

[19] Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-α antagonists [J].

Gottlieb, GS ;

Lesser, CF ;

Holmes, KK ;

Wald, A .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (06) :838-840

[20] Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-α therapy [J].

Hage, CA ;

Wood, KL ;

Winer-Muram, TH ;

Wilson, SJ ;

Sarosi, G ;

Knox, KS .

CHEST, 2003, 124 (06) :2395-2397

← 1 2 3 4 5 6 →